Inositol is a sugar alcohol that helps your body use glucose (sugar) more efficiently
When stratified by comparator groups, the pooled estimate was most favorable in monotherapy trials versus placebo (SMD 2.41, 95% CI 4.43 to 0.39), whereas the add-on designs versus the same background treatment (SMD 0.65, 95% CI 1.85 to 0.55), head-to-head comparisons versus another drug (SMD 0.19, 95% CI 0.84 to 0.45), and add-on designs versus placebo (SMD 0.65, 95% CI 1.35 to 0.06) showed more modest estimates and did not provide clear evidence of a between-group difference overall (p=0.21)
Evidence and UK Treatment Options Glucagon-like peptide-1 (GLP-1) receptor agonists, such as semaglutide and liraglutide, are licensed in the UK for type 2 diabetes and weight management
Another study a meta-analysis and review of 78 trials involving more than 73,000 participants concluded that semaglutide was associated with an increased incidence of NAION but emphasized that evidence for a causal link remains inconclusive
In the right patient, it can address the source of repeated bleeding more directly than symptom-only treatments